This is the best breakfast for fat loss, according to nutritionists
What’s the best breakfast for weight loss? It seems like a simple enough question to answer – keep it light and low in calories, right? For decades, we’ve been told that a bowl of cereal with skimmed milk, a piece of fruit or a low-fat yoghurt is the healthy way to start the day. But […]
Wegovy pill: Where to find Novo Nordisk’s new GLP-1 for weight loss—and how much it costs
For years, pharmaceutical companies have been racing to develop a market-ready GLP-1 weight-loss pill to join the ranks of popular injectables. Today, Novo Nordisk’s oral version of Wegovy is officially available for purchase. The Wegovy pill—which has been in clinical trials for over two years and was approved by the FDA on December 22—is the […]
Novo Nordisk’s GLP-1 weight-loss pill now available in U.S. pharmacies
Pharmaceutical company Novo Nordisk announced that a new pill-version of its GLP-1 weight-loss drug is now “broadly available” at U.S. pharmacies.
Arthur Brooks: Happiness Lessons from a Miserable Wretch
What is the secret to happiness? We’d like to believe there’s a silver bullet. That we can snap our fingers and dispel every source of despair, every tragedy, every inexplicably unfair event in the news. That the next app, the next pill, the next book, the next dietary restriction will finally quiet the crisis of […]
Novo Nordisk launches Wegovy weight-loss pill in US, triggering price war
First and only GLP-1 pill on the market costs significantly less than injectable versions The first pill version of the blockbuster GLP-1 weight loss drugs has been launched in the US by Novo Nordisk at a lower cost than jab varieties, accelerating a price war in the sector. The Danish pharmaceutical company said on Monday […]
Get a Jump Start on 2026 Health Goals with “New Year, New You” Sale at FSA Store® and HSA Store®
Health-E Commerce® helps consumers save even more when using tax-free flexible spending account (FSA) and health savings account (HSA) funds by offering discounts on eligible telehealth services, including mental health counseling, GLP-1 medications, vision care, oral health, and wearable…
Silicon Valley’s next risky self-optimization craze is unproven peptides
For many of these uses, the scientific backing is far weaker than that for GLP-1 drugs. Yet many users extrapolate from the proven success of GLP-1s to dozens of untested, unrelated peptides – often without randomized, placebo-controlled trials or independent, peer-reviewed publications. This dynamic blurs the line between legitimate pharmacology… Read Entire Article
The Weekly Whiskey – 01/05/2026
Full version can be found on Dread: https://dreadytofatroptsdj6io7l3xptbet6onoyno2yv7jicoxknyazubrad.onion/post/a9fa8a5deb3a54b33fb7 Tor browser is required to access any .onion links. 🦸 ✅ SUPERLIST MARKETS ✅ – /d/DarkMatterMarket – /d/DarkMatterMarket/wiki?id=0b1527ca – /d/Drughub – /d/DrugHub/wiki?id=45b4b777 – /d/TorZonMarket – /d/TorZonMarket/wiki?id=bb45a6f9 – /d/BlackOps – /d/BlackOps/wiki?id=f3947ea5 ❤️ WHAT’S HAPPENING ON DREAD? ❤️ New Year is coming, reminder to clean up old PM’s and […]
Reducing Early Stroke Recurrence Risk—Beyond Antithrombotics
About one-third of persons with ischemic strokes have diabetes, and an additional one-third have insulin resistance. After an ischemic stroke, diabetes is associated with approximately 20% higher risk of mortality, rehospitalizations, and ischemic stroke recurrence. Diabetes often occurs in the context of metabolic syndrome, obesity, hypertension, and dyslipidemia, which further compounds risk of downstream major […]
Coprescribing GLP-1 Receptor Agonists and Lifestyle
To the Editor The importance of integrating lifestyle modification when initiating glucagon-like peptide-1 and dual receptor agonists (GLP-1 RAs) for type 2 diabetes and/or obesity cannot be overstated. As referral to a registered dietitian or lifestyle medicine specialist is ideal but not always feasible, providing clinicians with practical, evidence-based resources for use when coprescribing GLP-1 […]